Mature

Defend access. Demonstrate value. Stay ahead.

In competitive environments post-launch, Novellia equips you with real-world evidence that demonstrates your value, identifies risks, and supports contract renewals.

Get Started
Why You Need RWE in the Mature Phase

You’ve launched successfully. Now come the challenges →

New competitors entering the class
Generic alternatives and biosimilars shifting payer priorities
Clinical guidelines evolving
Aggregated claims data that lacks granularity
Novellia equips you with the evidence you need to ensure patients continue to receive access to your treatments.
case study

Read Case Study

Key Capabilities for HEOR, Market Access & Medical Affairs

Prove enduring value in the real world
Go beyond claims to identify inclusion-ready cohorts, treatment journeys, and comorbidity patterns across 15+ years of linked EMRs.
Spot real-world variation before it affects patient care
Identify where care deviates from label or guidelines, and benchmark performance to support provider education and ongoing use.
Equip market access teams with negotiation-ready insights
Deliver payer-specific, population-stratified evidence to support renewals and respond to shifting access pressures in a crowded market.

What You Can Do With Novellia Mature

Market Access: Defend Coverage and Formulary Position Sentence description underneath
  • Quantify real-world performance against new entrants, biosimilars, and generics
  • Demonstrate outcomes and resource use to support renewals and rebating
  • Deliver payer-stratified data to tailor renegotiation strategy
HEOR: Strengthen and Refresh Your Value Narrative Sentence description underneath
  • Update models with real-patient outcomes across populations and settings
  • Highlight impact across comorbidities, demographics, and utilization
  • Provide access teams with evidence that reflects today’s treatment landscape
Medical Affairs: Detect Risk, Guide Strategy, and Engage Confidently
  • Monitor for safety signals, care gaps, and underperformance trends
  • Identify opportunities for potential label expansion
  • Equip MSLs with regional data and field-ready insights

See the whole story, find the pattern, drive better decisions

Our patient-powered database gives you a head start on real-world evidence. Fully structured, authorized, and ready for action.

Get Started

Frequently Asked Questions

Get answers to the most common questions about our platform, data, and results.
What makes Novellia different from traditional RWD vendors?

Unlike fragmented, ‘snapshot-in-time’ datasets, Novellia delivers patient-level, longitudinal records that are automatically cleaned and structured using AI to surface patterns, signals, and insights that traditional RWD simply can’t identify. We deliver precision insights, not just raw cohorts.

Where does your data come from?

Our dataset is sourced directly from patients who use Novellia to unify their health records from across providers, EMRs, and care sites nationwide. Every record is permissioned and structured to support longitudinal analysis.

Who typically uses Novellia inside a biopharma company?

Our primary users include teams in Medical Affairs, RWE/HEOR, Commercial Strategy, Market Access and R&D.

View All FAQs